Professor Matthew Weir
Baltimore (United States of America)
Renin-angiotensin-aldosterone system inhibitor therapy benefit and challenges in cardio-renal patients.
Event: ESC Congress 2017
Topic: Heart failure, other
Session: Enabling and optimising renin-angiotensin-aldosterone system inhibitor therapy in cardio-renal patients through hyperkalaemia management
Changing treatment paradigms in the management of chronic hyperkalaemia.
Event: HEART FAILURE 2016
Topic: Chronic heart failure
Session: Hyperkalaemia: are your patients missing out?
ESC 365 is supported by
